abstract |
The present invention relates to compounds of the formula (I), n n n n n n n n n n n n or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1 to R 4 are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection. |